Search
Search Results
##search.searchResults.foundPlural##
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3251PDF: 1927HTML: 7461 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1724PDF: 677HTML: 322 -
-
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1229PDF: 462HTML: 18551Figure 1: 154Figure 2: 138Figure 3: 156Figure 4: 189Figure 5: 160 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2123PDF: 1555HTML: 251 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2542PDF: 783HTML: 5194 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3118PDF: 1112HTML: 1469Untitled: 163Untitled: 152Untitled: 155 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1504PDF: 1173HTML: 173 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3154PDF: 754HTML: 2929Figure 1a and 1b: 139Figure 2: 146Figure 3: 167Figure 4: 147Figure 5: 151Tables 1-5: 144 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4271PDF: 1466HTML: 1536Untitled: 212 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
2990PDF: 1008HTML: 3064 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1936PDF: 1083HTML: 596 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1348PDF: 664HTML: 1071Untitled: 167Untitled: 138Untitled: 118Untitled: 140Untitled: 149 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1335HTML: 379PDF: 805 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2338PDF: 1564HTML: 598 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2204PDF: 864HTML: 1988Fig 1 Rossi: 162 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
965PDF: 537HTML: 67 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3338PDF: 1272HTML: 1853Fig.1: 187Fig. 2: 194 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2549PDF: 1584HTML: 2344Table1: 181 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2863PDF: 1564HTML: 222 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2509PDF: 938HTML: 15087 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
949PDF: 524HTML: 714 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1347PDF: 1281HTML: 84 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1041PDF: 823HTML: 86 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1804HTML: 1401PDF: 1053 -







